A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources
Abstract Animal models have been used to elucidate the pathophysiology of varying diseases and to provide insight into potential targets for therapeutic intervention. Although alternatives to animal testing have been proposed to help overcome potential drawbacks related to animal experiments and avo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Laboratory Animal Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.5625/lar.2018.34.4.232 |
id |
doaj-225e53b9f7a249c39b3d76dc3329a400 |
---|---|
record_format |
Article |
spelling |
doaj-225e53b9f7a249c39b3d76dc3329a4002020-11-25T02:11:15ZengBMCLaboratory Animal Research2233-76602018-12-0134423223810.5625/lar.2018.34.4.232A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sourcesSeunghyun Lee0Jae-Hwan Kwak1Sou Hyun Kim2Jieun Yun3Joon-Yong Cho4Kilsoo Kim5Daeyeon Hwang6Young-Suk Jung7College of Pharmacy, Pusan National UniversityCollege of Pharmacy, Brain Busan 21 Plus Program, Kyungsung UniversityCollege of Pharmacy, Pusan National UniversityDepartment of Pharmaceutical Engineering, Cheongju UniversityDepartment of Health and Exercise Science, Korea National Sport UniversityCollege of Veterinary Medicine, Kyungpook National UniversityCollege of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National UniversityCollege of Pharmacy, Pusan National UniversityAbstract Animal models have been used to elucidate the pathophysiology of varying diseases and to provide insight into potential targets for therapeutic intervention. Although alternatives to animal testing have been proposed to help overcome potential drawbacks related to animal experiments and avoid ethical issues, their use remains vital for the testing of new drug candidates and to identify the most effective strategies for therapeutic intervention. Particularly, the study of metabolic diseases requires the use of animal models to monitor whole-body physiology. In line with this, the National Institute of Food and Drug Safety Evaluation (NIFDS) in Korea has established their own animal strains to help evaluate both efficacy and safety during new drug development. The objective of this study was to characterize the response of C57BL/6NKorl mice from the NIFDS compared with that of other mice originating from the USA and Japan in a chemical-induced diabetic condition. Multiple low-dose treatments with streptozotocin were used to generate a type-1 diabetic animal model which is closely linked to the known clinical pathology of this disease. There were no significantly different responses observed between the varying streptozotocin-induced type-1 diabetic models tested in this study. When comparing control and diabetic mice, increases in liver weight and disturbances in serum amino acids levels of diabetic mice were most remarkable. Although the relationship between type-1 diabetes and BCAA has not been elucidated in this study, the results, which reveal a characteristic increase in diabetic mice of all origins are considered worthy of further study.http://link.springer.com/article/10.5625/lar.2018.34.4.232Type-1 diabetesstreptozotocinC57BL/6Nbranched-chain amino acids |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Seunghyun Lee Jae-Hwan Kwak Sou Hyun Kim Jieun Yun Joon-Yong Cho Kilsoo Kim Daeyeon Hwang Young-Suk Jung |
spellingShingle |
Seunghyun Lee Jae-Hwan Kwak Sou Hyun Kim Jieun Yun Joon-Yong Cho Kilsoo Kim Daeyeon Hwang Young-Suk Jung A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources Laboratory Animal Research Type-1 diabetes streptozotocin C57BL/6N branched-chain amino acids |
author_facet |
Seunghyun Lee Jae-Hwan Kwak Sou Hyun Kim Jieun Yun Joon-Yong Cho Kilsoo Kim Daeyeon Hwang Young-Suk Jung |
author_sort |
Seunghyun Lee |
title |
A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources |
title_short |
A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources |
title_full |
A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources |
title_fullStr |
A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources |
title_full_unstemmed |
A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources |
title_sort |
comparison of metabolomic changes in type-1 diabetic c57bl/6n mice originating from different sources |
publisher |
BMC |
series |
Laboratory Animal Research |
issn |
2233-7660 |
publishDate |
2018-12-01 |
description |
Abstract Animal models have been used to elucidate the pathophysiology of varying diseases and to provide insight into potential targets for therapeutic intervention. Although alternatives to animal testing have been proposed to help overcome potential drawbacks related to animal experiments and avoid ethical issues, their use remains vital for the testing of new drug candidates and to identify the most effective strategies for therapeutic intervention. Particularly, the study of metabolic diseases requires the use of animal models to monitor whole-body physiology. In line with this, the National Institute of Food and Drug Safety Evaluation (NIFDS) in Korea has established their own animal strains to help evaluate both efficacy and safety during new drug development. The objective of this study was to characterize the response of C57BL/6NKorl mice from the NIFDS compared with that of other mice originating from the USA and Japan in a chemical-induced diabetic condition. Multiple low-dose treatments with streptozotocin were used to generate a type-1 diabetic animal model which is closely linked to the known clinical pathology of this disease. There were no significantly different responses observed between the varying streptozotocin-induced type-1 diabetic models tested in this study. When comparing control and diabetic mice, increases in liver weight and disturbances in serum amino acids levels of diabetic mice were most remarkable. Although the relationship between type-1 diabetes and BCAA has not been elucidated in this study, the results, which reveal a characteristic increase in diabetic mice of all origins are considered worthy of further study. |
topic |
Type-1 diabetes streptozotocin C57BL/6N branched-chain amino acids |
url |
http://link.springer.com/article/10.5625/lar.2018.34.4.232 |
work_keys_str_mv |
AT seunghyunlee acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT jaehwankwak acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT souhyunkim acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT jieunyun acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT joonyongcho acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT kilsookim acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT daeyeonhwang acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT youngsukjung acomparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT seunghyunlee comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT jaehwankwak comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT souhyunkim comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT jieunyun comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT joonyongcho comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT kilsookim comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT daeyeonhwang comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources AT youngsukjung comparisonofmetabolomicchangesintype1diabeticc57bl6nmiceoriginatingfromdifferentsources |
_version_ |
1724915332482596864 |